How We Use Diverse Expression Platforms to Solve Problems for “Difficult-to-Express” Targets

Solving “Difficult-to-Express” Protein Challenges with Diverse Expression Platforms

Discover how Sygnature Discovery uses E. coli, Insect, HEK, and CHO cells to successfully express complex proteins for drug discovery and structural biology.

Learn which platform is best for your protein target and see real-world examples of how we overcame expression bottlenecks using tailored strategies.

👉 Download the free poster to explore our approach and accelerate your R&D success.